Allogene Therapeutics (ALLO) Interest & Investment Income (2021 - 2025)
Historic Interest & Investment Income for Allogene Therapeutics (ALLO) over the last 5 years, with Q3 2025 value amounting to $3.9 million.
- Allogene Therapeutics' Interest & Investment Income fell 4144.67% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year decrease of 2024.28%. This contributed to the annual value of $20.2 million for FY2024, which is 1008.36% up from last year.
- Latest data reveals that Allogene Therapeutics reported Interest & Investment Income of $3.9 million as of Q3 2025, which was down 4144.67% from $6.2 million recorded in Q2 2025.
- In the past 5 years, Allogene Therapeutics' Interest & Investment Income registered a high of $6.7 million during Q3 2024, and its lowest value of $186000.0 during Q4 2021.
- Its 5-year average for Interest & Investment Income is $3.3 million, with a median of $3.4 million in 2023.
- As far as peak fluctuations go, Allogene Therapeutics' Interest & Investment Income surged by 138225.81% in 2022, and later tumbled by 5168.4% in 2024.
- Quarter analysis of 5 years shows Allogene Therapeutics' Interest & Investment Income stood at $186000.0 in 2021, then soared by 1382.26% to $2.8 million in 2022, then soared by 127.24% to $6.3 million in 2023, then plummeted by 51.68% to $3.0 million in 2024, then increased by 29.7% to $3.9 million in 2025.
- Its last three reported values are $3.9 million in Q3 2025, $6.2 million for Q2 2025, and $5.5 million during Q1 2025.